I believe, like Senator Cruz just said, that the consumer ought to be the point of everything that we are trying to acco...
Our bill has guardrails. It does not give FTC any new power or regulatory authority.
I have long had concerns with the FTC's vague statutory authority, but at this moment, we cannot ignore the current stat...
Today, three PBMs control 80 percent of the market.
I worked at the FTC, and I can tell you that with the Agency's overreach and activism, which will no doubt be difficult ...
The Cantwell-Grassley PBM Transparency Act directs the FTC to end well-known and documented PBM practices that drive up ...
I've hauled Big Pharma and PBM executives before the Finance Committee.
Our investigation found that the PBM scheme encourages drug makers to spike the drug's list price in order to offer a gr...
FMI thanks Chairwoman Cantwell and Sen. Grassley for championing the PBM Transparency Act.
The Cantwell-Grassley PBM transparency bill directs the FTC to end well-known and documented PBM practices that drive up...
PBMs are blocking a cheaper product.
I hope this committee will have the same success voting this bill out.
It is shocking that a commissioner would choose to resign rather than watch an agency's bipartisan tradition crumble in ...
It requires the FTC to study pharmaceutical intermediaries and issue a report and recommendations to Congress within one...
Our investigation found that the PBM scheme encourages drug makers to spike the drug's list price.
Yes. I don't have a question, but you said--even though I have 1 and 12 seconds left, I'd like to just make a statement,...
Our rising deficits are cast by a lot of people as long-term challenge, but not immediate problem today.
I urge under your leadership to hold a hearing with CBO on the latest outlook.
